Skip to content

Insider · CIK 0001742557

John Kenneth Jenkins

director

Files at CRBP (Corbus Pharmaceuticals Holdings, Inc.). First filing Jun 2, 2025, latest Jun 2, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $20k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

CRBP: Corbus Pharmaceuticals Holdings, Inc.

CRBPOct 9, 2026 · close 5.38

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
23Weak
CRBPsell 210b5-1
Corbus Pharmaceuticals Holdings, Inc.
$20k
2,783 shares
-99%+51% from low-87% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
May 30, 2025CRBP
Corbus Pharmaceuticals Holdings, Inc.
SOpen-market sale
Common Stock, par value $0.0001 per share10b5-1
-2,783$7.35$20k33Jun 2, 2025
May 30, 2025CRBP
Corbus Pharmaceuticals Holdings, Inc.
AGrant or award
Common Stock, par value $0.0001 per share10b5-1
+4,800$0.00$04,833Jun 2, 2025
May 30, 2025CRBP
Corbus Pharmaceuticals Holdings, Inc.
AGrant or award
Stock options (right to buy)derivative10b5-1
+16,000$0.00$016,000Jun 2, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

John Kenneth Jenkins: insider trades and track record | InsiderTell